Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nasopharyngeal Neoplasms | 1 | 2017 | 285 | 0.480 |
Why?
|
High-Throughput Nucleotide Sequencing | 8 | 2023 | 3585 | 0.450 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 9 | 2023 | 5171 | 0.450 |
Why?
|
Lung Neoplasms | 15 | 2024 | 13019 | 0.440 |
Why?
|
Mutation | 17 | 2024 | 29717 | 0.400 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2017 | 569 | 0.380 |
Why?
|
NF-kappa B | 1 | 2017 | 2500 | 0.310 |
Why?
|
Lymphatic Metastasis | 1 | 2015 | 2906 | 0.290 |
Why?
|
Peptide Elongation Factor 1 | 1 | 2006 | 40 | 0.280 |
Why?
|
Protein Kinase Inhibitors | 7 | 2024 | 5522 | 0.280 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 5 | 2023 | 1683 | 0.280 |
Why?
|
Leishmania donovani | 1 | 2006 | 65 | 0.260 |
Why?
|
Molecular Targeted Therapy | 5 | 2021 | 2723 | 0.260 |
Why?
|
Carcinoma | 1 | 2017 | 2374 | 0.250 |
Why?
|
Sequence Analysis, Protein | 1 | 2006 | 257 | 0.250 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2020 | 5163 | 0.240 |
Why?
|
Models, Chemical | 1 | 2006 | 626 | 0.230 |
Why?
|
Drug Discovery | 1 | 2011 | 1057 | 0.220 |
Why?
|
Pharmaceutical Preparations | 1 | 2011 | 1071 | 0.220 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2016 | 4029 | 0.210 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2023 | 1631 | 0.200 |
Why?
|
Aneuploidy | 2 | 2023 | 530 | 0.200 |
Why?
|
Models, Molecular | 3 | 2016 | 5454 | 0.200 |
Why?
|
Sequence Alignment | 1 | 2006 | 2257 | 0.200 |
Why?
|
Ovarian Neoplasms | 3 | 2023 | 4823 | 0.200 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2016 | 890 | 0.190 |
Why?
|
Alkylating Agents | 1 | 2021 | 139 | 0.190 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2021 | 1659 | 0.190 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2021 | 187 | 0.180 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2020 | 144 | 0.180 |
Why?
|
Neoplasms | 4 | 2022 | 21596 | 0.170 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2020 | 195 | 0.170 |
Why?
|
Computational Biology | 1 | 2011 | 3518 | 0.170 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3564 | 0.170 |
Why?
|
Breast Neoplasms, Male | 1 | 2020 | 210 | 0.170 |
Why?
|
Arginase | 1 | 2019 | 79 | 0.170 |
Why?
|
Ribonucleoproteins | 1 | 2021 | 381 | 0.160 |
Why?
|
Pathology, Molecular | 1 | 2022 | 325 | 0.160 |
Why?
|
Papillomavirus Infections | 2 | 2023 | 1585 | 0.160 |
Why?
|
bcl-X Protein | 1 | 2019 | 411 | 0.150 |
Why?
|
TNF Receptor-Associated Factor 3 | 1 | 2017 | 40 | 0.150 |
Why?
|
Osteosarcoma | 1 | 2023 | 880 | 0.150 |
Why?
|
Glioma | 2 | 2022 | 3388 | 0.140 |
Why?
|
Proteins | 1 | 2011 | 6096 | 0.140 |
Why?
|
Viral Matrix Proteins | 1 | 2017 | 186 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2020 | 578 | 0.130 |
Why?
|
Bile Duct Neoplasms | 1 | 2021 | 567 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-ret | 2 | 2023 | 220 | 0.130 |
Why?
|
Cholangiocarcinoma | 1 | 2021 | 516 | 0.130 |
Why?
|
Receptors, Mitogen | 1 | 2015 | 62 | 0.130 |
Why?
|
Adenocarcinoma | 3 | 2023 | 6347 | 0.130 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5662 | 0.130 |
Why?
|
Myeloproliferative Disorders | 1 | 2021 | 603 | 0.130 |
Why?
|
Nuclear Proteins | 3 | 2021 | 5851 | 0.130 |
Why?
|
Receptor, Notch1 | 2 | 2016 | 502 | 0.130 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2016 | 704 | 0.130 |
Why?
|
Central Nervous System Neoplasms | 1 | 2023 | 895 | 0.130 |
Why?
|
Pancreatic Neoplasms | 2 | 2023 | 5249 | 0.130 |
Why?
|
Receptor, Notch2 | 1 | 2015 | 89 | 0.120 |
Why?
|
ras GTPase-Activating Proteins | 1 | 2015 | 101 | 0.120 |
Why?
|
Myeloid Cells | 1 | 2019 | 804 | 0.120 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2019 | 1158 | 0.120 |
Why?
|
Exons | 1 | 2020 | 2431 | 0.120 |
Why?
|
Signal Transduction | 1 | 2017 | 23387 | 0.120 |
Why?
|
Neutrophil Infiltration | 1 | 2016 | 390 | 0.110 |
Why?
|
Cell Line, Tumor | 9 | 2021 | 16665 | 0.110 |
Why?
|
Serine | 1 | 2016 | 828 | 0.110 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1581 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2021 | 8425 | 0.110 |
Why?
|
Phenylcarbamates | 1 | 2011 | 38 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinase 14 | 1 | 2011 | 28 | 0.100 |
Why?
|
Herpesvirus 4, Human | 1 | 2017 | 1040 | 0.100 |
Why?
|
Tosyl Compounds | 1 | 2011 | 110 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2023 | 2011 | 0.100 |
Why?
|
Humans | 38 | 2024 | 742088 | 0.100 |
Why?
|
Colorectal Neoplasms | 2 | 2021 | 6754 | 0.100 |
Why?
|
Base Sequence | 3 | 2022 | 12797 | 0.100 |
Why?
|
Adaptive Immunity | 1 | 2016 | 712 | 0.100 |
Why?
|
Bone Neoplasms | 1 | 2023 | 2522 | 0.090 |
Why?
|
Transcription Factors | 3 | 2021 | 12164 | 0.090 |
Why?
|
Dendritic Cells | 1 | 2021 | 2723 | 0.090 |
Why?
|
Brain Neoplasms | 2 | 2022 | 8829 | 0.090 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2016 | 2940 | 0.090 |
Why?
|
Aged, 80 and over | 9 | 2022 | 57683 | 0.090 |
Why?
|
Databases, Protein | 1 | 2011 | 383 | 0.090 |
Why?
|
Reproducibility of Results | 2 | 2022 | 19862 | 0.090 |
Why?
|
Glioblastoma | 1 | 2024 | 3456 | 0.080 |
Why?
|
AMP-Activated Protein Kinases | 3 | 2016 | 608 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2023 | 9185 | 0.080 |
Why?
|
Sequence Analysis, DNA | 2 | 2020 | 4801 | 0.080 |
Why?
|
Aged | 14 | 2023 | 162944 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2016 | 2948 | 0.080 |
Why?
|
Genome, Human | 2 | 2020 | 4420 | 0.080 |
Why?
|
Software | 1 | 2021 | 4434 | 0.070 |
Why?
|
Apoptosis | 2 | 2021 | 9715 | 0.070 |
Why?
|
Protein Binding | 2 | 2011 | 9387 | 0.070 |
Why?
|
Protein Kinase C | 1 | 2011 | 1227 | 0.070 |
Why?
|
Middle Aged | 14 | 2023 | 213127 | 0.070 |
Why?
|
Indoles | 2 | 2011 | 1834 | 0.070 |
Why?
|
DNA Helicases | 2 | 2021 | 861 | 0.060 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2020 | 3557 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2015 | 2938 | 0.060 |
Why?
|
Gene Expression Profiling | 3 | 2016 | 9410 | 0.060 |
Why?
|
Genomics | 4 | 2021 | 5692 | 0.060 |
Why?
|
Male | 16 | 2023 | 349538 | 0.060 |
Why?
|
Prognosis | 5 | 2023 | 29010 | 0.060 |
Why?
|
Female | 15 | 2023 | 379592 | 0.050 |
Why?
|
DNA Methylation | 1 | 2016 | 4282 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2022 | 15494 | 0.050 |
Why?
|
Sulfonamides | 1 | 2011 | 1932 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2016 | 2712 | 0.050 |
Why?
|
Species Specificity | 1 | 2006 | 2479 | 0.050 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2006 | 2837 | 0.050 |
Why?
|
Amino Acid Substitution | 1 | 2006 | 1792 | 0.050 |
Why?
|
Loss of Heterozygosity | 1 | 2023 | 678 | 0.050 |
Why?
|
Antineoplastic Agents | 3 | 2019 | 13655 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2017 | 10472 | 0.050 |
Why?
|
Cytokines | 1 | 2016 | 7317 | 0.050 |
Why?
|
Adult | 11 | 2022 | 213712 | 0.050 |
Why?
|
Sucrose | 1 | 2021 | 164 | 0.050 |
Why?
|
Immunotherapy | 1 | 2016 | 4414 | 0.050 |
Why?
|
Mice | 8 | 2020 | 81045 | 0.040 |
Why?
|
Chromosomes | 1 | 2023 | 595 | 0.040 |
Why?
|
Young Adult | 6 | 2022 | 56350 | 0.040 |
Why?
|
Pyrimidines | 1 | 2011 | 2933 | 0.040 |
Why?
|
Animals | 10 | 2020 | 168561 | 0.040 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2021 | 364 | 0.040 |
Why?
|
Gene Amplification | 1 | 2023 | 1062 | 0.040 |
Why?
|
BRCA2 Protein | 1 | 2023 | 790 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2016 | 10163 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2020 | 800 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 2 | 2023 | 4553 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2022 | 1086 | 0.040 |
Why?
|
Binding Sites | 1 | 2006 | 6115 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 424 | 0.040 |
Why?
|
BRCA1 Protein | 1 | 2023 | 1145 | 0.040 |
Why?
|
Oncogenes | 1 | 2022 | 1263 | 0.040 |
Why?
|
Chromosome Aberrations | 1 | 2023 | 1811 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2016 | 53 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1263 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 627 | 0.030 |
Why?
|
Gender Identity | 1 | 2021 | 681 | 0.030 |
Why?
|
Transaminases | 1 | 2016 | 199 | 0.030 |
Why?
|
Retroelements | 1 | 2016 | 164 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2023 | 1786 | 0.030 |
Why?
|
S-Adenosylmethionine | 1 | 2016 | 212 | 0.030 |
Why?
|
Documentation | 1 | 2021 | 865 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2016 | 563 | 0.030 |
Why?
|
Pancreatic Ducts | 1 | 2016 | 328 | 0.030 |
Why?
|
Chromatin | 2 | 2016 | 2917 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11472 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2015 | 459 | 0.030 |
Why?
|
Ligands | 1 | 2021 | 3293 | 0.030 |
Why?
|
Cohort Studies | 3 | 2022 | 40450 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2455 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2006 | 13814 | 0.030 |
Why?
|
Cyclin D1 | 1 | 2016 | 462 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2028 | 0.030 |
Why?
|
Immunoblotting | 1 | 2016 | 1683 | 0.030 |
Why?
|
Cisplatin | 1 | 2019 | 1637 | 0.030 |
Why?
|
Glycine | 1 | 2016 | 671 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 20774 | 0.030 |
Why?
|
Azepines | 1 | 2015 | 336 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3587 | 0.030 |
Why?
|
Genome | 1 | 2021 | 1803 | 0.030 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 18112 | 0.030 |
Why?
|
Glycolysis | 1 | 2016 | 825 | 0.030 |
Why?
|
Computer Simulation | 1 | 2006 | 6191 | 0.030 |
Why?
|
Receptors, Virus | 1 | 2016 | 648 | 0.030 |
Why?
|
Paclitaxel | 1 | 2019 | 1707 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 2016 | 1097 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4187 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
Neoplasm Proteins | 2 | 2016 | 3691 | 0.020 |
Why?
|
Drug Design | 1 | 2016 | 1078 | 0.020 |
Why?
|
DNA Repair | 1 | 2020 | 2042 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2020 | 9639 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3133 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1038 | 0.020 |
Why?
|
DNA Damage | 1 | 2020 | 2423 | 0.020 |
Why?
|
Gene Silencing | 1 | 2016 | 1538 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6534 | 0.020 |
Why?
|
Benzenesulfonates | 1 | 2010 | 169 | 0.020 |
Why?
|
Triazoles | 1 | 2015 | 907 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1337 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1905 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1613 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1670 | 0.020 |
Why?
|
Tongue Neoplasms | 1 | 2010 | 179 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39004 | 0.020 |
Why?
|
Mice, Nude | 1 | 2015 | 3689 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18006 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2010 | 376 | 0.020 |
Why?
|
Niacinamide | 1 | 2010 | 416 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2107 | 0.020 |
Why?
|
Phenylurea Compounds | 1 | 2010 | 526 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2016 | 6382 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2020 | 11001 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2015 | 2556 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12773 | 0.020 |
Why?
|
Gene Dosage | 1 | 2010 | 1251 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2016 | 3800 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2010 | 914 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2010 | 1284 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6891 | 0.020 |
Why?
|
Child | 2 | 2023 | 77478 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5867 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2016 | 3678 | 0.020 |
Why?
|
Pyrroles | 1 | 2010 | 1143 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7790 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 77098 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11363 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 85649 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16331 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2010 | 2502 | 0.010 |
Why?
|
Lung | 1 | 2020 | 9826 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9274 | 0.010 |
Why?
|
Pyridines | 1 | 2010 | 2818 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 21821 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53187 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 62966 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 35342 | 0.010 |
Why?
|